["Asthmatic children--active children. New therapeutic methods using Formoterol." Press conference Novartis Pharma Ltd. Frankfurt, 24 April 1998].
D000293:Adolescent; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D004983:Ethanolamines / Q000627:therapeutic use*; D015444:Exercise; D005260:Female; D000068759:Formoterol Fumarate; D006801:Humans; D008019:Life Style; D008297:Male
D001993:Bronchodilator Agents; D004983:Ethanolamines; D000068759:Formoterol Fumarate